secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tectonic Therapeutic, Inc. (TECX)
CIK:        0001681087
Form:       8-K
Filed at:   2022-06-10T23:59:59+00:00
Accession:  0001564590-22-022999
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AVROBIO stockholders approve plan amendment increasing authorized shares to 13,486,099
--------------------------------------------------------------------------------

- Elected Gail Farfel, Christopher Paige, and Philip Vickers as Class I directors with over 20M votes each.
- Ratified Ernst & Young as independent auditor for FY2022 with 33.8M votes for, 57,906 against.
- Approved amendment to 2018 Stock Plan adding 13,486,099 shares and imposing 12-month minimum vesting (excluding 5% pool).
- Shares forfeited after March 2, 2022 will be added back to the plan reserve under the amended terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681087/000156459022022999/0001564590-22-022999-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681087/000156459022022999/avro-8k_20220608.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-022999

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer